CONCLUSIONS: The intravesical combination of BCG with murinized PD1-IL2v selectively increases the number of cytotoxic CD8+ TILs, but not Tregs, and improves the survival of the mice in the preclinical model of bladder cancer model. Here, CD8A is linked to urinary bladder cancer.